Transition from insulin to oral sulfonylurea therapy in children with diabetes due to activating mutations in KCNJ11

被引：0
|
作者：
Greeley, Siri Atma W.
Bordini, Brian D.
Edidin, Deborah V.
Littlejohn, Elizabeth E.
Philipson, Louis H.
机构：
来源：
DIABETES | 2007年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A699 / A699
页数：1
相关论文
共 50 条
  • [21] Transient Neonatal Diabetes due to Kcnj11 Mutation
    Kochar, I. P. S.
    Kulkarni, K. P.
    INDIAN PEDIATRICS, 2010, 47 (04) : 359 - 360
  • [22] Sulfonylurea vs insulin therapy in individuals with sulfonylurea-sensitive permanent neonatal diabetes mellitus, attributable to a KCNJ11 mutation, and poor glycaemic control
    Stanik, J.
    Dankovcikova, A.
    Barak, L.
    Skopkova, M.
    Palko, M.
    Divinec, J.
    Klimes, I.
    Gasperikova, D.
    DIABETIC MEDICINE, 2018, 35 (03) : 386 - 391
  • [23] Monogenic diabetes due to mutation in the KCNJ11 gene
    Frapolli, Victor Jose Simon
    Montalban, Angel Lopez
    Cesar, Maria Jose Picon
    MEDICINA CLINICA, 2024, 163 (03): : 154 - 155
  • [24] Successful transfer from insulin to oral sulfonylurea in a 3-year-old girl with a mutation in the KCNJ11 gene
    Al-Mahdi, Maria
    Al Mutair, Angham
    Al Balwi, Mohammed
    Hussain, Khalid
    ANNALS OF SAUDI MEDICINE, 2010, 30 (02) : 162 - 164
  • [25] Insulin independence with sulphonylurea treatment in a series of patients with permanent neonatal diabetes due to heterozygous activating mutations in the KCNJ11 (Kir6.2) gene
    Pearson, ER
    Flechtner, I
    Ellard, S
    Robert, JJ
    Clark, PM
    Hamilton-Shield, JP
    Polak, M
    Hattersley, AT
    DIABETOLOGIA, 2005, 48 : A113 - A114
  • [26] Transfer from Insulin to Sulfonylurea Treatment in a Chinese Patient with Permanent Neonatal Diabetes Mellitus due to a KCNJ11 R201H Mutation
    Xiao, X.
    Wang, T.
    Li, W.
    Song, H.
    Gong, C.
    Diao, C.
    Yu, M.
    Yuan, T.
    Zhang, Y.
    Sun, X.
    Zhang, Q.
    Lu, K.
    Wang, H.
    Schmitz, O.
    Hansen, T.
    HORMONE AND METABOLIC RESEARCH, 2009, 41 (07) : 580 - 582
  • [27] Psychiatric morbidity in children with KCNJ11 neonatal diabetes
    Bowman, P.
    Broadbridge, E.
    Knight, B. A.
    Pettit, L.
    Flanagan, S. E.
    Reville, M.
    Tonks, J.
    Shepherd, M. H.
    Ford, T. J.
    Hattersley, A. T.
    DIABETIC MEDICINE, 2016, 33 (10) : 1387 - 1391
  • [28] Permanent neonatal diabetes by a new mutation in KCNJ11: unsuccessful switch to sulfonylurea
    Lau, Eva
    Correia, Cintia
    Freitas, Paula
    Nogueira, Cladia
    Costa, Maria
    Saavedra, Ana
    Costa, Carla
    Carvalho, Davide
    Fontoura, Manuel
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2015, 59 (06): : 559 - 561
  • [29] Transient neonatal diabetes with two novel mutations in the KCNJ11 gene and response to sulfonylurea treatment in a preterm infant
    Siklar, Zeynep
    Ellard, Sian
    Okulu, Emel
    Berberoglu, Merih
    Young, Elizabeth
    Erdeve, Senay Savas
    Mungan, Ilke Akin
    Hacihamdioglu, Bulent
    Erdeve, Omer
    Arsan, Saadet
    Ocal, Gonul
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2011, 24 (11-12): : 1077 - 1080
  • [30] Successful transition from insulin to sulfonylurea, on second attempt, in a 24-year-old female with neonatal diabetes secondary to KCNJ11 gene mutation
    Hajji, Sulaiman
    Aljenaee, Khaled
    Garrahy, Aoife
    Byrne, Maria
    BMJ CASE REPORTS, 2021, 14 (04)
12345